Prosper Diagnostics

clinical diagnostics has become a fundamental component of health care. diagnostic tests allow clinicians to establish disease diagnosis as well as monitor disease progression. diagnostic tests and biomarkers have been developed for a large panel of medical conditions, including cancers, allergies, infectious diseases, and general health. integration and miniaturization of assays with microfluidic technology has drastic consequences on assay throughput. we developed a microfluidic platform that can interrogate thousands of samples in a single assay, and at significantly reduced cost. such technological innovations will result in a paradigm shift in the diagnostics industry. in the near future it will be possible to conduct routine tests for hundreds of biomarkers from minute blood samples at a highly competitive and affordable value. as a result it will be possible to diagnose diseases at much earlier stages, leading to an enormous reduction in treatment associated costs, and more im